 Corporate Presentation to Highlight Companys Gene Therapies for Cancer and Diabetes AUSTIN, Texas , Sept. 8, 2022 PRNewswire -- Genprex, Inc. Genprex or the Company NASDAQ: GNPX, a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that its Chief Financial Officer, Ryan Confer, will be providing a virtual overview of the Companys gene therapies for cancer and diabetes at the following investor conference in September 2022. 